

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adhesion of symbiont to host cell (GO:0044650) | 8.95126986 |
| 2 | virion attachment to host cell (GO:0019062) | 8.95126986 |
| 3 | cellular extravasation (GO:0045123) | 8.16585474 |
| 4 | adhesion of symbiont to host (GO:0044406) | 7.84844313 |
| 5 | regulation of activation of Janus kinase activity (GO:0010533) | 7.08317177 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.11476504 |
| 7 | wound healing, spreading of epidermal cells (GO:0035313) | 6.00876384 |
| 8 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 5.81622926 |
| 9 | activated T cell proliferation (GO:0050798) | 5.72244083 |
| 10 | T-helper 1 type immune response (GO:0042088) | 5.64988279 |
| 11 | lipoxygenase pathway (GO:0019372) | 5.50733650 |
| 12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.49116202 |
| 13 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.31593387 |
| 14 | regulation of apoptotic cell clearance (GO:2000425) | 5.31169925 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 5.27020118 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.20617861 |
| 17 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.14710840 |
| 18 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 5.09551138 |
| 19 | pinocytosis (GO:0006907) | 4.84493018 |
| 20 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.79472458 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.79407967 |
| 22 | negative T cell selection (GO:0043383) | 4.79247751 |
| 23 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.75898834 |
| 24 | regulation of memory T cell differentiation (GO:0043380) | 4.75581201 |
| 25 | mannose metabolic process (GO:0006013) | 4.73510662 |
| 26 | positive regulation of interleukin-12 production (GO:0032735) | 4.65349496 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 4.58666065 |
| 28 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.58092694 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.57735999 |
| 30 | negative regulation of interleukin-17 production (GO:0032700) | 4.55907592 |
| 31 | eosinophil chemotaxis (GO:0048245) | 4.50764315 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.47727789 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 4.45806694 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 4.45299023 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 4.44747488 |
| 36 | apoptotic cell clearance (GO:0043277) | 4.43686059 |
| 37 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.40249299 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.39924288 |
| 39 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.38245252 |
| 40 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.35149026 |
| 41 | wound healing, spreading of cells (GO:0044319) | 4.33772077 |
| 42 | granulocyte activation (GO:0036230) | 4.33348154 |
| 43 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.29040507 |
| 44 | regulation of T-helper cell differentiation (GO:0045622) | 4.27453642 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.23166143 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.20609683 |
| 47 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.19915496 |
| 48 | natural killer cell mediated immunity (GO:0002228) | 4.19915496 |
| 49 | positive regulation of interferon-alpha production (GO:0032727) | 4.16475013 |
| 50 | neutrophil activation (GO:0042119) | 4.16403306 |
| 51 | defense response to protozoan (GO:0042832) | 4.10792339 |
| 52 | response to peptidoglycan (GO:0032494) | 4.04416775 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.04017813 |
| 54 | regulation of immunoglobulin secretion (GO:0051023) | 4.00642329 |
| 55 | glycolipid catabolic process (GO:0019377) | 3.99748416 |
| 56 | myeloid dendritic cell differentiation (GO:0043011) | 3.99268907 |
| 57 | eosinophil migration (GO:0072677) | 3.97804023 |
| 58 | respiratory burst (GO:0045730) | 3.89235615 |
| 59 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.88636102 |
| 60 | negative regulation of adaptive immune response (GO:0002820) | 3.88363111 |
| 61 | positive regulation of interleukin-17 production (GO:0032740) | 3.88191569 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 3.88028157 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.85272009 |
| 64 | homeostasis of number of cells within a tissue (GO:0048873) | 3.85255062 |
| 65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.83296263 |
| 66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.79808474 |
| 67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.79292333 |
| 68 | positive regulation of activated T cell proliferation (GO:0042104) | 3.79044894 |
| 69 | natural killer cell differentiation (GO:0001779) | 3.76420321 |
| 70 | regulation of T-helper 1 type immune response (GO:0002825) | 3.74768576 |
| 71 | monocyte chemotaxis (GO:0002548) | 3.72231766 |
| 72 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.71303971 |
| 73 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.70522967 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69554664 |
| 75 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.68428816 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.68153477 |
| 77 | regulation of mononuclear cell migration (GO:0071675) | 3.66686817 |
| 78 | modulation by virus of host morphology or physiology (GO:0019048) | 3.65219986 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.65065002 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.65065002 |
| 81 | regulation of RIG-I signaling pathway (GO:0039535) | 3.64103126 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 3.63329870 |
| 83 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.61436471 |
| 84 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.61033843 |
| 85 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.59450448 |
| 86 | response to type I interferon (GO:0034340) | 3.58639878 |
| 87 | superoxide anion generation (GO:0042554) | 3.58150294 |
| 88 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.56590762 |
| 89 | reactive oxygen species biosynthetic process (GO:1903409) | 3.56505648 |
| 90 | ceramide catabolic process (GO:0046514) | 3.56104032 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.53419880 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 3.53419880 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.52820889 |
| 94 | regulation of interleukin-12 production (GO:0032655) | 3.51404653 |
| 95 | cellular response to interferon-beta (GO:0035458) | 3.50743332 |
| 96 | positive regulation of interleukin-2 production (GO:0032743) | 3.50527262 |
| 97 | cellular response to zinc ion (GO:0071294) | 3.50079000 |
| 98 | regulation of mast cell activation (GO:0033003) | 3.49011757 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.45844112 |
| 100 | positive thymic T cell selection (GO:0045059) | 3.43775543 |
| 101 | positive regulation of interleukin-10 production (GO:0032733) | 3.43457631 |
| 102 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.40374642 |
| 103 | B cell mediated immunity (GO:0019724) | 3.38895784 |
| 104 | thymic T cell selection (GO:0045061) | 3.38450313 |
| 105 | response to protozoan (GO:0001562) | 3.37930126 |
| 106 | positive regulation of macrophage cytokine production (GO:0060907) | 3.37699871 |
| 107 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.36111637 |
| 108 | positive regulation of immune response to tumor cell (GO:0002839) | 3.35881256 |
| 109 | regulation of immune response to tumor cell (GO:0002837) | 3.35881256 |
| 110 | regulation of response to tumor cell (GO:0002834) | 3.35881256 |
| 111 | positive regulation of response to tumor cell (GO:0002836) | 3.35881256 |
| 112 | regulation of interleukin-17 production (GO:0032660) | 3.35392729 |
| 113 | regulation of hypersensitivity (GO:0002883) | 3.30800379 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.30651727 |
| 115 | positive regulation of response to biotic stimulus (GO:0002833) | 3.27530897 |
| 116 | natural killer cell activation (GO:0030101) | 3.26328486 |
| 117 | response to muramyl dipeptide (GO:0032495) | 3.25603300 |
| 118 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25369829 |
| 119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24667033 |
| 120 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.24454643 |
| 121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24320989 |
| 122 | nerve growth factor signaling pathway (GO:0038180) | 3.23740288 |
| 123 | negative regulation of type 2 immune response (GO:0002829) | 3.23491566 |
| 124 | regulation of chronic inflammatory response (GO:0002676) | 3.22995942 |
| 125 | negative regulation of viral genome replication (GO:0045071) | 3.21609996 |
| 126 | T-helper cell differentiation (GO:0042093) | 3.21411994 |
| 127 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.21411994 |
| 128 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20413796 |
| 129 | regulation of type 2 immune response (GO:0002828) | 3.18141604 |
| 130 | leukocyte cell-cell adhesion (GO:0007159) | 3.17733466 |
| 131 | signal peptide processing (GO:0006465) | 3.16563142 |
| 132 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14482131 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12550804 |
| 134 | T cell selection (GO:0045058) | 3.12393961 |
| 135 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.12333200 |
| 136 | positive regulation of chemokine secretion (GO:0090197) | 3.12328539 |
| 137 | T cell costimulation (GO:0031295) | 3.11486887 |
| 138 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11036185 |
| 139 | leukocyte mediated cytotoxicity (GO:0001909) | 3.10979566 |
| 140 | positive regulation of T cell cytokine production (GO:0002726) | 3.09184325 |
| 141 | regulation of monocyte chemotaxis (GO:0090025) | 3.08643956 |
| 142 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08197036 |
| 143 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07425666 |
| 144 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07425666 |
| 145 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07425666 |
| 146 | regulation of growth of symbiont in host (GO:0044126) | 3.07425666 |
| 147 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.06701423 |
| 148 | lymphocyte costimulation (GO:0031294) | 3.06645426 |
| 149 | dendritic cell differentiation (GO:0097028) | 3.05916648 |
| 150 | cellular response to interferon-alpha (GO:0035457) | 3.05607783 |
| 151 | positive regulation of tissue remodeling (GO:0034105) | 3.04395337 |
| 152 | positive regulation of T cell proliferation (GO:0042102) | 3.03725420 |
| 153 | germinal center formation (GO:0002467) | 3.03464934 |
| 154 | regulation of mast cell degranulation (GO:0043304) | 3.03109314 |
| 155 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.02999628 |
| 156 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01571123 |
| 157 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.99393729 |
| 158 | cellular response to exogenous dsRNA (GO:0071360) | 2.99290983 |
| 159 | positive regulation of isotype switching (GO:0045830) | 2.98716289 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.98419191 |
| 161 | intracellular pH reduction (GO:0051452) | 2.98401325 |
| 162 | macrophage differentiation (GO:0030225) | 2.96232152 |
| 163 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.92525391 |
| 164 | positive regulation of neutrophil migration (GO:1902624) | 2.92525391 |
| 165 | membrane lipid catabolic process (GO:0046466) | 2.91333303 |
| 166 | positive regulation of bone remodeling (GO:0046852) | 2.90611084 |
| 167 | positive regulation of bone resorption (GO:0045780) | 2.90611084 |
| 168 | detection of bacterium (GO:0016045) | 2.89646577 |
| 169 | protein localization to endosome (GO:0036010) | 2.85261996 |
| 170 | pH reduction (GO:0045851) | 2.82593687 |
| 171 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.82300864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.09957581 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.82591333 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.10095608 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.32383455 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.31847399 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.22024050 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.79619242 |
| 8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.72247951 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57742667 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.45265379 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31112269 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05965014 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97701726 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94007355 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.90031434 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82439464 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55410443 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25622887 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19580798 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00339493 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97428278 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96773287 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84141451 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83105162 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.75762693 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74535721 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66103277 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64772337 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62071722 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59284546 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58450854 |
| 32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56659245 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55485794 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54077043 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53540481 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50311376 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49452917 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47196925 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46791816 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46407121 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.46318064 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43601142 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42565258 |
| 44 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42134022 |
| 45 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40822990 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40802792 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38690713 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35547968 |
| 49 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34817498 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32951137 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30659627 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30062757 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29066546 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29043197 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29043197 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28391452 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.25426913 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21665275 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20683339 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20162093 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19577513 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19393285 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18168271 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17687832 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12455810 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11431765 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.07977631 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07104846 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04055005 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03836004 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02568429 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02483157 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01406049 |
| 74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01027709 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00786995 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98900299 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98824797 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97442348 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97178863 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94817223 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94773507 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94556336 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94299185 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93851935 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93403280 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93016695 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92517953 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90815702 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89737409 |
| 90 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89292846 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87563017 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86668338 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86225600 |
| 94 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86212364 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85873626 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85615791 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85035588 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84312128 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83444439 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82859257 |
| 101 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81254973 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80476768 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80150023 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80134363 |
| 105 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79792997 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79405035 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.78841511 |
| 108 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78771044 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78523120 |
| 110 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78415859 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76700570 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76623178 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76623178 |
| 114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74183698 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70058497 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69962512 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67934138 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67488777 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.67345049 |
| 120 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64770361 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.63898684 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.63520722 |
| 123 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.63453369 |
| 124 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.61603894 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59188093 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.56889130 |
| 127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55634148 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.52607836 |
| 129 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.52551852 |
| 130 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.52546982 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50383579 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.49529782 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.49349868 |
| 134 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.48835104 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.47347434 |
| 136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.47300657 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.46814629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.82460134 |
| 2 | MP0009785_altered_susceptibility_to | 4.92013257 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 4.68930342 |
| 4 | MP0003436_decreased_susceptibility_to | 4.07375464 |
| 5 | MP0001958_emphysema | 4.03152314 |
| 6 | MP0000685_abnormal_immune_system | 3.98604301 |
| 7 | MP0008004_abnormal_stomach_pH | 3.77621445 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.52147546 |
| 9 | * MP0005671_abnormal_response_to | 3.42565924 |
| 10 | MP0003279_aneurysm | 3.42216646 |
| 11 | MP0005025_abnormal_response_to | 3.40096486 |
| 12 | MP0001790_abnormal_immune_system | 3.21666922 |
| 13 | MP0005387_immune_system_phenotype | 3.21666922 |
| 14 | MP0002419_abnormal_innate_immunity | 3.11284839 |
| 15 | MP0006082_CNS_inflammation | 2.89786718 |
| 16 | MP0003303_peritoneal_inflammation | 2.84375306 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.70767940 |
| 18 | MP0002723_abnormal_immune_serum | 2.68373361 |
| 19 | MP0004510_myositis | 2.66922251 |
| 20 | MP0003724_increased_susceptibility_to | 2.55775204 |
| 21 | MP0001800_abnormal_humoral_immune | 2.46344615 |
| 22 | MP0009764_decreased_sensitivity_to | 2.41384189 |
| 23 | MP0002006_tumorigenesis | 2.36744923 |
| 24 | MP0001819_abnormal_immune_cell | 2.34625788 |
| 25 | MP0001853_heart_inflammation | 2.34623329 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.25871108 |
| 27 | MP0005647_abnormal_sex_gland | 2.19801446 |
| 28 | MP0001727_abnormal_embryo_implantation | 2.18437032 |
| 29 | MP0000015_abnormal_ear_pigmentation | 2.07550821 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 2.07158804 |
| 31 | MP0005451_abnormal_body_composition | 2.04383655 |
| 32 | MP0003448_altered_tumor_morphology | 1.97312499 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.90005717 |
| 34 | MP0002405_respiratory_system_inflammati | 1.84397050 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.77424095 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.77316371 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.73605571 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.69712914 |
| 39 | MP0008469_abnormal_protein_level | 1.69272243 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.69202683 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.66388939 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.66052256 |
| 43 | MP0000716_abnormal_immune_system | 1.64995800 |
| 44 | MP0004947_skin_inflammation | 1.64862826 |
| 45 | MP0005310_abnormal_salivary_gland | 1.62287177 |
| 46 | MP0002971_abnormal_brown_adipose | 1.62133807 |
| 47 | MP0009115_abnormal_fat_cell | 1.62118480 |
| 48 | MP0003186_abnormal_redox_activity | 1.54989832 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.54277133 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.54098971 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.51413364 |
| 52 | MP0002398_abnormal_bone_marrow | 1.50148117 |
| 53 | MP0002163_abnormal_gland_morphology | 1.49336397 |
| 54 | MP0003075_altered_response_to | 1.49054619 |
| 55 | MP0005670_abnormal_white_adipose | 1.48826009 |
| 56 | MP0000858_altered_metastatic_potential | 1.44431795 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.31787113 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.31787113 |
| 59 | MP0001849_ear_inflammation | 1.30127209 |
| 60 | MP0000343_altered_response_to | 1.29287369 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.26685677 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.23528832 |
| 63 | MP0002429_abnormal_blood_cell | 1.22732704 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.20512878 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.15265872 |
| 66 | MP0008874_decreased_physiological_sensi | 1.13524534 |
| 67 | MP0005166_decreased_susceptibility_to | 1.13060651 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.09899387 |
| 69 | MP0009763_increased_sensitivity_to | 1.08594340 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.05702424 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.04839831 |
| 72 | MP0002722_abnormal_immune_system | 1.00185674 |
| 73 | MP0000689_abnormal_spleen_morphology | 0.99531810 |
| 74 | MP0002254_reproductive_system_inflammat | 0.96126435 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.96020009 |
| 76 | MP0001881_abnormal_mammary_gland | 0.91357157 |
| 77 | MP0002295_abnormal_pulmonary_circulatio | 0.90310736 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.88780416 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.87683313 |
| 80 | MP0003091_abnormal_cell_migration | 0.87525820 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.86933896 |
| 82 | MP0005164_abnormal_response_to | 0.84971892 |
| 83 | MP0004742_abnormal_vestibular_system | 0.82993427 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.80720826 |
| 85 | MP0005390_skeleton_phenotype | 0.79524575 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.79065698 |
| 87 | MP0010329_abnormal_lipoprotein_level | 0.78129916 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.78018669 |
| 89 | MP0005334_abnormal_fat_pad | 0.77901622 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.76922142 |
| 91 | MP0002133_abnormal_respiratory_system | 0.76573765 |
| 92 | MP0005388_respiratory_system_phenotype | 0.76573765 |
| 93 | MP0008057_abnormal_DNA_replication | 0.75505449 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.74889299 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.74711395 |
| 96 | MP0006138_congestive_heart_failure | 0.74456541 |
| 97 | MP0000627_abnormal_mammary_gland | 0.73239121 |
| 98 | MP0005408_hypopigmentation | 0.72278878 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.71894727 |
| 100 | MP0003690_abnormal_glial_cell | 0.70104204 |
| 101 | MP0003828_pulmonary_edema | 0.69331577 |
| 102 | MP0002075_abnormal_coat/hair_pigmentati | 0.69261661 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.69120504 |
| 104 | MP0000249_abnormal_blood_vessel | 0.67439567 |
| 105 | MP0008260_abnormal_autophagy | 0.66982048 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.66432695 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.64668888 |
| 108 | MP0002933_joint_inflammation | 0.63734581 |
| 109 | MP0010307_abnormal_tumor_latency | 0.63132064 |
| 110 | MP0000371_diluted_coat_color | 0.62442689 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.61760955 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.61281115 |
| 113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60909466 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.60317197 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.60097191 |
| 116 | MP0003172_abnormal_lysosome_physiology | 0.59690436 |
| 117 | MP0002970_abnormal_white_adipose | 0.58490168 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.58378558 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.57619445 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57254803 |
| 121 | MP0003634_abnormal_glial_cell | 0.57243050 |
| 122 | MP0000604_amyloidosis | 0.56156503 |
| 123 | MP0005171_absent_coat_pigmentation | 0.55230570 |
| 124 | MP0003866_abnormal_defecation | 0.55103934 |
| 125 | MP0003646_muscle_fatigue | 0.53793102 |
| 126 | MP0003195_calcinosis | 0.52226872 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.52030778 |
| 128 | MP0005535_abnormal_body_temperature | 0.51803156 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.51477742 |
| 130 | MP0004883_abnormal_blood_vessel | 0.50650255 |
| 131 | MP0001851_eye_inflammation | 0.49498285 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.49205411 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.48747537 |
| 134 | MP0003191_abnormal_cellular_cholesterol | 0.47904646 |
| 135 | MP0009278_abnormal_bone_marrow | 0.47441572 |
| 136 | MP0000920_abnormal_myelination | 0.46651372 |
| 137 | MP0003941_abnormal_skin_development | 0.46239257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.34432048 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.66696642 |
| 3 | Increased IgM level (HP:0003496) | 6.62716888 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.53474858 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 6.40831593 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.38294695 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.85254289 |
| 8 | Protuberant abdomen (HP:0001538) | 5.62677670 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.89351761 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.89262432 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.85131089 |
| 12 | Vasculitis (HP:0002633) | 4.55849467 |
| 13 | Basal ganglia calcification (HP:0002135) | 4.52992188 |
| 14 | Steatorrhea (HP:0002570) | 4.39285147 |
| 15 | Stomatitis (HP:0010280) | 4.19133096 |
| 16 | Recurrent skin infections (HP:0001581) | 4.06769042 |
| 17 | Hypercholesterolemia (HP:0003124) | 4.06689428 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.98455302 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.95159530 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.94735400 |
| 21 | Gingivitis (HP:0000230) | 3.87508379 |
| 22 | Hypergammaglobulinemia (HP:0010702) | 3.79809995 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74382935 |
| 24 | Upper motor neuron abnormality (HP:0002127) | 3.58804080 |
| 25 | Obstructive lung disease (HP:0006536) | 3.55437559 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55437559 |
| 27 | Polygenic inheritance (HP:0010982) | 3.50262657 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.40790461 |
| 29 | Myositis (HP:0100614) | 3.40760527 |
| 30 | Optic neuritis (HP:0100653) | 3.39361546 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.39361546 |
| 32 | Recurrent viral infections (HP:0004429) | 3.38925672 |
| 33 | Porencephaly (HP:0002132) | 3.28507253 |
| 34 | Orchitis (HP:0100796) | 3.25492367 |
| 35 | Multiple lipomas (HP:0001012) | 3.25346603 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.23979620 |
| 37 | Tetraparesis (HP:0002273) | 3.22164885 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 3.17661208 |
| 39 | Loss of speech (HP:0002371) | 3.17427018 |
| 40 | Spontaneous hematomas (HP:0007420) | 3.14884236 |
| 41 | Poor head control (HP:0002421) | 3.14827801 |
| 42 | Fat malabsorption (HP:0002630) | 3.13644555 |
| 43 | Amaurosis fugax (HP:0100576) | 3.07731079 |
| 44 | Hemoptysis (HP:0002105) | 3.04912584 |
| 45 | Cellulitis (HP:0100658) | 3.02339655 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.97648931 |
| 47 | Abdominal distention (HP:0003270) | 2.91120434 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90888443 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90888443 |
| 50 | Axonal loss (HP:0003447) | 2.90403064 |
| 51 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.88800809 |
| 52 | Mutism (HP:0002300) | 2.88147785 |
| 53 | Recurrent pneumonia (HP:0006532) | 2.86510365 |
| 54 | Urticaria (HP:0001025) | 2.83717451 |
| 55 | Flat cornea (HP:0007720) | 2.82916166 |
| 56 | Chest pain (HP:0100749) | 2.82543978 |
| 57 | Gingival bleeding (HP:0000225) | 2.73801675 |
| 58 | Thoracic kyphosis (HP:0002942) | 2.73763340 |
| 59 | Gangrene (HP:0100758) | 2.70713881 |
| 60 | Colitis (HP:0002583) | 2.70687488 |
| 61 | Cortical dysplasia (HP:0002539) | 2.69090817 |
| 62 | Arterial thrombosis (HP:0004420) | 2.69043554 |
| 63 | IgA deficiency (HP:0002720) | 2.67769754 |
| 64 | Cheilitis (HP:0100825) | 2.67250622 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.64403750 |
| 66 | Peritonitis (HP:0002586) | 2.64171146 |
| 67 | Scanning speech (HP:0002168) | 2.63384740 |
| 68 | Hypertensive crisis (HP:0100735) | 2.59482849 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58214138 |
| 70 | Thick nail (HP:0001805) | 2.58004911 |
| 71 | Periodontitis (HP:0000704) | 2.57788587 |
| 72 | Leukocytosis (HP:0001974) | 2.57113608 |
| 73 | Meningitis (HP:0001287) | 2.56373383 |
| 74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.55019491 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.52534137 |
| 76 | Myocardial infarction (HP:0001658) | 2.48461430 |
| 77 | Anorexia (HP:0002039) | 2.47118615 |
| 78 | Chronic otitis media (HP:0000389) | 2.45696456 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45602976 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45602976 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45602976 |
| 82 | Distal lower limb muscle weakness (HP:0009053) | 2.44898731 |
| 83 | Pustule (HP:0200039) | 2.38044296 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.37987701 |
| 85 | Petechiae (HP:0000967) | 2.37513318 |
| 86 | Joint swelling (HP:0001386) | 2.36643375 |
| 87 | Arthralgia (HP:0002829) | 2.35660012 |
| 88 | Thin bony cortex (HP:0002753) | 2.33531845 |
| 89 | Purpura (HP:0000979) | 2.31733689 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.30447249 |
| 91 | Esophageal varix (HP:0002040) | 2.30004483 |
| 92 | Abnormality of the lumbar spine (HP:0100712) | 2.29385865 |
| 93 | Pulmonary hypertension (HP:0002092) | 2.28321501 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.27517653 |
| 95 | Albinism (HP:0001022) | 2.25681171 |
| 96 | Glomerulonephritis (HP:0000099) | 2.20773142 |
| 97 | Peripheral hypomyelination (HP:0007182) | 2.20259800 |
| 98 | Adactyly (HP:0009776) | 2.18903021 |
| 99 | Spondylolisthesis (HP:0003302) | 2.16868651 |
| 100 | Cleft eyelid (HP:0000625) | 2.14906637 |
| 101 | Agnosia (HP:0010524) | 2.14710239 |
| 102 | Abnormality of the pericardium (HP:0001697) | 2.14516695 |
| 103 | Cerebral ischemia (HP:0002637) | 2.13471483 |
| 104 | Thrombocytosis (HP:0001894) | 2.13220875 |
| 105 | Abnormality of the basal ganglia (HP:0002134) | 2.12064685 |
| 106 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11844948 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 2.10569106 |
| 108 | Osteomyelitis (HP:0002754) | 2.10353026 |
| 109 | Parakeratosis (HP:0001036) | 2.09270391 |
| 110 | Apathy (HP:0000741) | 2.09224026 |
| 111 | Mucosal telangiectasiae (HP:0100579) | 2.09158421 |
| 112 | Eosinophilia (HP:0001880) | 2.09134015 |
| 113 | Diminished motivation (HP:0000745) | 2.09019036 |
| 114 | Premature loss of primary teeth (HP:0006323) | 2.08908192 |
| 115 | Nephritis (HP:0000123) | 2.08600651 |
| 116 | Viral hepatitis (HP:0006562) | 2.08020077 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07958747 |
| 118 | Progressive visual loss (HP:0000529) | 2.07878577 |
| 119 | IgG deficiency (HP:0004315) | 2.07580697 |
| 120 | Prostate neoplasm (HP:0100787) | 2.05959517 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04989354 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04989354 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04989354 |
| 124 | Flat occiput (HP:0005469) | 2.03400431 |
| 125 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01443708 |
| 126 | Disinhibition (HP:0000734) | 2.00995354 |
| 127 | Mucopolysacchariduria (HP:0008155) | 2.00461210 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00461210 |
| 129 | Vertebral compression fractures (HP:0002953) | 2.00398429 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.99281716 |
| 131 | Xerostomia (HP:0000217) | 1.99262323 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.98531917 |
| 133 | Sepsis (HP:0100806) | 1.98313996 |
| 134 | Prolonged neonatal jaundice (HP:0006579) | 1.97014014 |
| 135 | Recurrent bronchitis (HP:0002837) | 1.95613764 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.95579659 |
| 137 | Hematochezia (HP:0002573) | 1.95310017 |
| 138 | Skin ulcer (HP:0200042) | 1.94970102 |
| 139 | Lower limb hyperreflexia (HP:0002395) | 1.94246213 |
| 140 | T lymphocytopenia (HP:0005403) | 1.93659704 |
| 141 | Abnormality of T cells (HP:0002843) | 1.93047905 |
| 142 | Amyloidosis (HP:0011034) | 1.91058174 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.90902733 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.90640986 |
| 145 | Bone pain (HP:0002653) | 1.90389917 |
| 146 | Abnormality of T cell physiology (HP:0011840) | 1.89150014 |
| 147 | Exertional dyspnea (HP:0002875) | 1.88887362 |
| 148 | Abnormality of the thoracic spine (HP:0100711) | 1.87949460 |
| 149 | Tinnitus (HP:0000360) | 1.87891572 |
| 150 | Abnormality of the pleura (HP:0002103) | 1.87491062 |
| 151 | Lymphopenia (HP:0001888) | 1.86734955 |
| 152 | Personality changes (HP:0000751) | 1.85584612 |
| 153 | Congenital hepatic fibrosis (HP:0002612) | 1.85288137 |
| 154 | Femoral bowing (HP:0002980) | 1.84465135 |
| 155 | Keratoconjunctivitis sicca (HP:0001097) | 1.84090271 |
| 156 | Supernumerary nipples (HP:0002558) | 1.84072814 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.83930156 |
| 158 | Abnormality of eosinophils (HP:0001879) | 1.83446007 |
| 159 | Abnormality of the peritoneum (HP:0002585) | 1.81342171 |
| 160 | Onion bulb formation (HP:0003383) | 1.81284314 |
| 161 | Restrictive lung disease (HP:0002091) | 1.80338297 |
| 162 | Acrocyanosis (HP:0001063) | 1.78953169 |
| 163 | Cardiomegaly (HP:0001640) | 1.78950059 |
| 164 | Bulbar palsy (HP:0001283) | 1.76555023 |
| 165 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76530823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.67319120 |
| 2 | PBK | 5.46267247 |
| 3 | RIPK4 | 4.85726304 |
| 4 | JAK3 | 3.63584463 |
| 5 | TBK1 | 3.59524896 |
| 6 | BLK | 3.20975216 |
| 7 | IRAK4 | 3.00216653 |
| 8 | IKBKB | 2.97686134 |
| 9 | TTN | 2.97616484 |
| 10 | TYK2 | 2.95953861 |
| 11 | MAP3K13 | 2.93677012 |
| 12 | PIM2 | 2.84239965 |
| 13 | PRPF4B | 2.60045933 |
| 14 | IKBKE | 2.31782001 |
| 15 | CDC42BPA | 2.05186865 |
| 16 | BMPR2 | 1.99923618 |
| 17 | CHUK | 1.94678722 |
| 18 | NEK9 | 1.92362808 |
| 19 | CAMK1D | 1.88972492 |
| 20 | NME2 | 1.77076309 |
| 21 | CAMK1G | 1.77014240 |
| 22 | ITK | 1.73133778 |
| 23 | IRAK3 | 1.69546764 |
| 24 | ABL2 | 1.69035851 |
| 25 | ARAF | 1.66974677 |
| 26 | JAK1 | 1.66973800 |
| 27 | PIK3CG | 1.61212624 |
| 28 | MST4 | 1.58507363 |
| 29 | TXK | 1.49961612 |
| 30 | CAMKK2 | 1.44170320 |
| 31 | STK4 | 1.41477508 |
| 32 | RPS6KA2 | 1.40355831 |
| 33 | SIK3 | 1.38668901 |
| 34 | BMX | 1.31660424 |
| 35 | CAMKK1 | 1.31531635 |
| 36 | CDK6 | 1.30921000 |
| 37 | ERBB3 | 1.30882835 |
| 38 | SYK | 1.27719141 |
| 39 | MAP4K1 | 1.19643188 |
| 40 | JAK2 | 1.14693351 |
| 41 | PIM1 | 1.07967290 |
| 42 | DAPK2 | 1.04909351 |
| 43 | MAP3K8 | 1.01210179 |
| 44 | SMG1 | 0.99969661 |
| 45 | TESK1 | 0.98649670 |
| 46 | CSK | 0.98104340 |
| 47 | PDPK1 | 0.98094632 |
| 48 | TAOK3 | 0.97292380 |
| 49 | MARK3 | 0.96498276 |
| 50 | TRPM7 | 0.95693067 |
| 51 | BCR | 0.94991784 |
| 52 | PDK1 | 0.92685340 |
| 53 | ZAP70 | 0.92373697 |
| 54 | KIT | 0.91536679 |
| 55 | TESK2 | 0.91424418 |
| 56 | MST1R | 0.88839847 |
| 57 | EIF2AK2 | 0.88680566 |
| 58 | BTK | 0.86799747 |
| 59 | HCK | 0.83950796 |
| 60 | RPS6KC1 | 0.83753671 |
| 61 | RPS6KL1 | 0.83753671 |
| 62 | RPS6KA4 | 0.82244677 |
| 63 | LYN | 0.82081595 |
| 64 | STK24 | 0.81327955 |
| 65 | PRKCQ | 0.81320843 |
| 66 | EPHB1 | 0.79682350 |
| 67 | LCK | 0.79667079 |
| 68 | SGK3 | 0.79654345 |
| 69 | CDK12 | 0.79184654 |
| 70 | EEF2K | 0.77565911 |
| 71 | FGFR3 | 0.77050210 |
| 72 | YES1 | 0.75532833 |
| 73 | MAPKAPK3 | 0.75383702 |
| 74 | MAP3K12 | 0.68257667 |
| 75 | IRAK2 | 0.67969406 |
| 76 | IRAK1 | 0.67399684 |
| 77 | RPS6KA6 | 0.67235516 |
| 78 | MAP3K2 | 0.66712242 |
| 79 | MAP3K5 | 0.65210764 |
| 80 | PRKCD | 0.64999997 |
| 81 | BCKDK | 0.63227369 |
| 82 | MAPK12 | 0.60829230 |
| 83 | ERN1 | 0.60559318 |
| 84 | ABL1 | 0.59792430 |
| 85 | SGK2 | 0.58372879 |
| 86 | MAPK7 | 0.57999867 |
| 87 | ADRBK2 | 0.57990163 |
| 88 | ERBB4 | 0.53202720 |
| 89 | MAP3K11 | 0.51846215 |
| 90 | MAPKAPK5 | 0.51812156 |
| 91 | MATK | 0.50926485 |
| 92 | SCYL2 | 0.48172580 |
| 93 | FGR | 0.47800608 |
| 94 | MOS | 0.47455968 |
| 95 | MAP3K6 | 0.46669306 |
| 96 | GRK7 | 0.45367443 |
| 97 | RET | 0.45011948 |
| 98 | TGFBR2 | 0.44587033 |
| 99 | DAPK3 | 0.43771307 |
| 100 | EPHA3 | 0.43330421 |
| 101 | FGFR4 | 0.43279228 |
| 102 | MAPKAPK2 | 0.41099972 |
| 103 | CSF1R | 0.40731444 |
| 104 | PRKACB | 0.40010134 |
| 105 | SIK2 | 0.39878226 |
| 106 | EGFR | 0.39746451 |
| 107 | MAP2K4 | 0.39567923 |
| 108 | PKN2 | 0.39364236 |
| 109 | FYN | 0.38590070 |
| 110 | PAK1 | 0.36019866 |
| 111 | MAP3K9 | 0.35075755 |
| 112 | PKN1 | 0.34865437 |
| 113 | STK3 | 0.34498707 |
| 114 | BMPR1B | 0.33922015 |
| 115 | KSR1 | 0.33648091 |
| 116 | WNK4 | 0.33582271 |
| 117 | KSR2 | 0.33018048 |
| 118 | MAP3K1 | 0.32713673 |
| 119 | STK39 | 0.32602456 |
| 120 | DAPK1 | 0.31852068 |
| 121 | MAPK4 | 0.29584031 |
| 122 | TAOK2 | 0.29272253 |
| 123 | RIPK1 | 0.28435686 |
| 124 | LRRK2 | 0.27833841 |
| 125 | FES | 0.27725060 |
| 126 | RPS6KB1 | 0.25721833 |
| 127 | WNK1 | 0.25477860 |
| 128 | PRKCE | 0.25423407 |
| 129 | RPS6KA1 | 0.25390733 |
| 130 | ROCK1 | 0.23961313 |
| 131 | TRIB3 | 0.23267835 |
| 132 | NLK | 0.20789816 |
| 133 | TEC | 0.20291225 |
| 134 | MAPK3 | 0.20009510 |
| 135 | RAF1 | 0.17271936 |
| 136 | BRAF | 0.16952304 |
| 137 | SRC | 0.16382268 |
| 138 | PLK2 | 0.16155354 |
| 139 | DYRK1B | 0.15908250 |
| 140 | LIMK1 | 0.13105989 |
| 141 | SIK1 | 0.12426783 |
| 142 | INSR | 0.11868831 |
| 143 | IGF1R | 0.11681190 |
| 144 | PTK2B | 0.10894576 |
| 145 | GSK3A | 0.10398658 |
| 146 | PRKACG | 0.10348498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.98519441 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.24078244 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.53701559 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.38470520 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.99841888 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90371753 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.89567910 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56372200 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55510350 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.52898911 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46521920 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.43240129 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.39421121 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.35795018 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.30390364 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.24634251 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.15842318 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.07554126 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.05856495 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.99053664 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91469308 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.84168975 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.81260162 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79474849 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79078710 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71677157 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68054143 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56410482 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.54541285 |
| 30 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49937945 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49507208 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36202419 |
| 33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34243734 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33155812 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.31406869 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25838855 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.20359894 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19666573 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.18155664 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16610350 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15419469 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14078283 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13073392 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02875589 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01625372 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96785405 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.94938316 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93849663 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92334432 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.90230398 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.86297015 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85497539 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83695959 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 0.80876789 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79873922 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.76899610 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76072594 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75740694 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.71736310 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65595131 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64305972 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59152365 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55173243 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55006609 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53177284 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51418701 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50320951 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48831130 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46740419 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43631577 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39277647 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39191027 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38946511 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38833413 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38742968 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38146557 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36189220 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36182644 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35500757 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34988139 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.33902130 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.33855186 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32473890 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31136549 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30453132 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.29992263 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29258948 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.28059373 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27867123 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.27247685 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26526349 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26196476 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25503938 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23536032 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22978925 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22372022 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21039645 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20127795 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.19519080 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18652908 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18497114 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17190567 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16299498 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15565723 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14990608 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14512743 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14304174 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13407639 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.13010693 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.12885097 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12884002 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.12556021 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12121263 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11734902 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10444624 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09040369 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07913518 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07490510 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07080835 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06785713 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.02757297 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.02503557 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.02091849 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.01496394 |

